American Society of Hirudotherapy

Leech Substance P Modulator

Salivary factor reported to modulate the substance P / neurokinin-1 nociceptive pathway.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 26, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Leech Substance P Modulator14 kDa
Molecular weight (kilodaltons) of Leech Substance P Modulator (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
Mechanistic discussion
Drug vs leech
Purified natural compound

Clinical translation limit

Leech substance P modulator is documented mechanistically only; no human evidence. Hypothesized nociceptive modulation does NOT establish clinical analgesic efficacy, and no FDA-approved derivative exists.

Molecular Profile

Category
Analgesic
Evidence tier
Preclinical
Molecular weight
14,000 Da
Source species
Hirudo medicinalis
Discovered
2018

Biological Targets

  • → substance P signaling
  • → neurokinin-1 receptor pathway

Key Citations

  1. Liu Z et al. (2019), Parasit Vectors

External Resources

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.